Art made with AI is selling for over $1 million and being embraced by some of the world's most prestigious museums, but ...
In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results